Novo Nordisk CEO to Testify on High Prices of Ozempic, Wegovy
Senate subpoenas Novo's Langa over drug pricing; Jorgensen to testify in September as Novo blames U.S. health system for high ...
- Latest
- Trending
Senate subpoenas Novo's Langa over drug pricing; Jorgensen to testify in September as Novo blames U.S. health system for high ...
Altimmune's stock has seen a strong increase in value, surpassing Eli Lilly and Novo Nordisk. However, there are risks involved.
Pfizer's interest in the weight loss market is uncertain due to its significant debt of over $70 billion and recent ...
Sales of iPhones and Teslas have slumped in China, while the success of the maker of Ozempic and Wegovy is ...
Investigation reveals significant delays in processing complaints against UK drug companies, raising concerns about patient safety and public health. Increased ...
The weight-loss drugs of Eli Lilly and Novo Nordisk have led to soaring share prices as investors anticipate high demand ...
Denmark's stock market achieves new heights, reflecting investor confidence and potential growth. Leading performers drive market optimism while some companies ...
A new wave of companies is racing to achieve trillion-dollar valuations, joining household names like Apple and Microsoft. Berkshire Hathaway, ...
The health care sector is witnessing a surge as drug shortages and rising prices create opportunities for growth. However, concerns ...
Denmark's stock market experiences significant growth as the OMX Copenhagen 20 surges by 1.34%, driven by leading performers like Novozymes ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.